FINECARE™ MYO RAPID QUANTITATIVE TEST
INMUNOENSAYO DE FLUORESCENCIA PARA LA DETERMINACIÓN CUANTITATIVA DE MIOGLOBINA EN SANGRE COMPLETA, SUERO O PLASMA HUMANO. AGENTE DE DIAGNÓSTICO IN VITRO PARA USO EXCLUSIVO DE LABORATORIOS CLÍNICOS Y/O DE GABINETE
FLUORESCENCE IMMUNOASSAY FOR THE QUANTITATIVE DETERMINATION OF MYOGLOBIN IN WHOLE BLOOD, SERUM OR HUMAN PLASMA. IN VITRO DIAGNOSTIC AGENT FOR CLINICAL AND/OR CABINET USE ONLY
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- CARTUCHO DE PRUEBA PARA LA CUANTIFICACION DE LA MIOGLOBINA (MYO)
- Trade Name (English)
- MYOGLOBIN (MYO) QUANTIFICATION TEST CARTRIDGE
- Analysis ID
- 5R2019 SSA
- Registration Date
- January 14, 2019
- Name (Spanish)
- DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.
- Name (English)
- DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.
Access comprehensive regulatory information for FINECARE™ MYO RAPID QUANTITATIVE TEST (FINECARE™ MYO RAPID QUANTITATIVE TEST) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 5R2019 SSA and manufactured by DISTRIBUIDORA QUÍMICA INTEGRAL, S.A. DE C.V.. The device was registered on January 14, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.